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Abstract
Background: New technologies make it possible for the first time to genotype hundreds of
thousands of SNPs simultaneously. A wealth of genomic information in the form of publicly available
databases is underutilized as a potential resource for uncovering functionally relevant markers
underlying complex human traits. Given the huge amount of SNP data available from the annotation
of human genetic variation, data mining is a reasonable approach to investigating the number of
SNPs that are informative for ancestry information.
Methods: The distribution and density of SNPs across the genome of African and European
populations were extensively investigated by using the HapMap, Affymetrix, and Illumina SNP
databases. We exploited these resources by mining the data available from each of these databases
to prioritize potential candidate SNPs useful for admixture mapping in complex human diseases and
traits. Over 4 million SNPs were compared between Africans and Europeans on the basis of a pre-
specified recommended allele frequency difference (delta) value of ≥ 0.3.
Results: The method identified 15% of HapMap, 11% of Affymetrix, and 14% of Illumina SNP sets
as candidate SNPs, termed ancestry informative markers (AIMs). These AIM panels with assigned
rs numbers, allele frequencies in each ethnic group, delta value, and map positions are all posted
on our website http://www.ssg.uab.edu/downloads/admixture_mapping/SNPAIMs.txt. All marker
information in this data set is freely and publicly available without restriction.
Conclusion: The selected SNP sets represent valuable resources for admixture mapping studies.
The overlap between selected AIMs by this single measure of marker informativeness in the
different platforms is discussed.
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Background
The chromosome of an individual from a recently
admixed population such as the African-American popu-
lation contains large stretches of DNA that resemble
mosaics of chromosomal segments [1], each derived from
European or African ancestry that have not had sufficient
time to break up as a result of recombination. Hence,
allelic associations in these populations may extend over
distances as large as 20–30 cM [2,3]. Methods to map
genes that rely on admixture may therefore require fewer
markers to screen the genome than would other
approaches for mapping complex disease genes [4,5].
Theoretically, any marker [6-10] that has an allele fre-
quency difference between ancestral populations, known
as ancestry informative markers (AIMs), can be used for
admixture mapping. Such markers can also be used to
control for population confounding by variations in back-
ground ancestry via structural association testing (SAT)
[11]. The ideal AIM has one allele that is monomorphic in
one population (p = 1.0) and that is not present in
another [12]. However, most alleles are shared among
populations [13-15]. Hence, it is important to identify
and choose informative AIMs across populations [16].
Several single nucleotide polymorphism (SNP) panels
have been reported over the past few years [7,8,16-19]
with a focus on identifying markers suitable for admixture
studies. Smith et al. [9] screened 744 microsatellite mark-
ers for AIMs in 4 different populations and identified a
genome spanning set of 315 markers (average spacing 10
cM, frequency difference > 0.3) for mapping in African-
Americans and 214 markers (average spacing of 16 cM,
frequency difference > 0.25) for mapping in Hispanics.
Ninety-seven AIMs were identified for mapping in Afri-
can-American populations that show limited variation
within Africa [10].
Recently 3011 SNP AIMs were reported for studying Afri-
can-American populations [19], who have an average of
80% African and 20% European ancestry, after screening
450,000 SNPs for which allele frequencies were available.
This panel is considered the gold standard for admixture
mapping in this population. However, the SNPs used to
develop these AIMs came mostly from African-American
(98.6%, over 443,916 SNPs) populations, and the ances-
tral West African frequencies were inferred or estimated by
using the expectation-maximization (EM) algorithm [20]
rather than by being directly measured.
To date, only a limited amount of information character-
izing SNPs across the human genome [21,22] for the
majority of ethnic groups is found in the literature [23].
Consequently, mining of SNP frequencies from HapMap
and other genomic data sets including Affymetrix 500 K
and Illumina 100 K SNPs with an ethnic-dependent back-
ground across the genome is an economical, rapid, and
practical strategy for developing a more comprehensive
and informative panel of AIMs [19,24]. This may result in
a uniform resource that describes nucleotide diversity
with sufficient power to infer ancestry for admixed popu-
lations [25], beyond the currently available lists of AIMs.
The objectives of the present study were to mine databases
and develop AIM panels useful in admixture mapping and
compare the selected set of AIMs with the widely used
AIM panels.
Methods
Materials
SNP markers deposited by the HapMap project, 500 K
Affymetrix, 100 K Illumina, and the recently published
3011AIM SNP panels for all autosomal and sex chromo-
somes were used to determine AIMs. The distribution of
SNPs in each chromosome and database is shown in
Table 1.
Data mining, processing, and description
We downloaded the HapMap allele frequency data (http:/
/www.hapmap.org, March 13, 2007 release). The Hap-
Table 1: Number of SNPs investigated for data-mining of AIMs 
for each chromosome for both Yorubans and European 
populations listed by genotypic platform or source.
Chr HapMap 500 k Affymetrix 100 k Illumina AIMs
1 286584 39418 9820 241
2 304922 40633 8702 230
3 235256 33120 7207 190
4 224433 31339 6000 132
5 230257 31595 6329 136
6 251838 31130 6579 192
7 196235 25407 5581 124
8 199358 26948 4891 129
9 169079 22596 4480 115
10 197292 28217 5240 144
11 189407 28217 5240 144
12 177798 25998 5928 164
13 146641 24712 5465 129
14 114909 18910 3093 76
15 99603 15432 3420 91
16 101959 14190 3307 87
17 83339 15069 3388 103
18 111158 11127 4079 130
19 51689 14631 2570 83
20 111869 6284 3520 117
21 45994 12266 3007 83
22 51037 7014 1381 59
X 103517 6123 1886 94
Y5 4 - - -
Total 3684228 492556 109366 3011
Chr = chromosomeBioData Mining 2009, 2:1 http://www.biodatamining.org/content/2/1/1
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Map project contains genotypes from 60 unrelated indi-
viduals (parents) from Yorubans in Ibadan, Nigeria [YRI]
and 60 unrelated (parents) Caucasians from the United
States with northern and western European ancestry
[CEU]. There are ~5.8 million SNPs in the combined
phase 1 and phase 2 HapMap projects [26,27].
The Affymetrix 500 K was downloaded from http://
www.affymetrix.com. The Affymetrix 500 K array sets con-
tain "quasi-random" or anonymous SNPs that are spread
evenly across the genome and are selected on the basis of
information content and could lie between genes. These
SNPs were developed for genome-wide association and
fine mapping studies. The sample sizes used to generate
allele frequency datasets of the 500 K SNP array consist of
48 samples containing 13 trios (5 HapMap CEU trios, 5
HapMap Yoruban trios, and 3 other non-HapMap trios)
and 9 unrelated HapMap Asian samples. In total, 39 of the
48 samples are parts of the samples used in the HapMap
project. About 365,000 or 73% of the Affymetrix 500 K
SNPs have also been typed by the HapMap Project.
The Illumina 100 K was downloaded from http://
www.illumina.com. This panel is a gene-centric collection
of SNPs (70% of which are located in exons or within 10
kb of transcripts) developed for genome-wide association
studies. The sample sizes used to generate the Illumina
100 K allele frequency data were 32 CEU and 28 Yoru-
bans. Close to 57,000 of the Illumina 100 K SNPs are in
the HapMap project. The recently selected panel of 3011
AIM allele frequencies was obtained from http://
www.cell.com/AJHG/supplemental/S0002-
9297(07)64364-X. A total of 66 European Americans and
64 African Americans genotyped by different platforms
were used to generate the 3011 AIMs from the total of
450,000 SNPs screened.
Each of these data sets, which differ in the way the SNPs
were selected [28], has characteristics that make it useful
for the current investigation. The HapMap offers an exten-
sive collection of SNPs across ancestral population
genomes; the Affymetrix 500 K is a comprehensive widely
used chip; the Illumina 100 K has a gene-centric focus;
and the AIM panel is the current gold standard SNP panel
used in admixture mapping.
Data analysis
A computer program using Python http://
www.python.org was written to export and pre-process
the SNP information from the HapMap databases (the
codes are available upon request). A SAS [29] program
was used to analyze the data. We used 3 criteria to select
the markers to be considered in our analysis: (1) the SNP
should be shared between the 2 ancestral populations, (2)
a specific marker is retained if it has a delta-value (i.e., the
allele frequency difference between 2 parental popula-
tions) of 0.3 or higher (a cutoff that has been suggested for
AIMs [10], and (3) the physical distance between consec-
utive selected SNPs must be at least 0.3 cM to avoid the
probability of choosing 2 redundant SNPs that are in
strong LD [30,31]. It is expected that markers that are suf-
ficiently spaced throughout the genome will offer inde-
pendent information about genetic background or
ancestry. In each of the 0.3 cM bin, AIMs with the highest
delta value were selected to maximize information con-
tent of ancestry.
Several methods for measuring marker informativeness
for ancestry have been developed and discussed by Rosen-
berg et al. [12] and others [19,32]. However, the absolute
allele frequency difference (delta) is the most commonly
used measure of informativeness for ancestry between 2
parental populations [12]. Marker informativeness for
ancestry can be ascertained through the absolute value of
the difference in the frequency of a particular allele
observed for 2 ancestral populations. If we let p11 repre-
sent the frequency of a reference allele in the first parental
population and p21 the frequency of the same allele in the
second parental population, then the delta value is given
by   = |p11 - p12|. A marker with a delta value of 1 provides
perfect information regarding its ancestry, whereas a
marker with a delta value of 0 carries no information for
ancestry.
Results
1. SNP allele frequency characterization, racial variation, 
and databases
Of the total HapMap SNPs for which both Yoruban and
CEU allele frequencies were available, we extracted all the
monomorphic SNPs and SNPs with various levels of pol-
ymorphism, including 100% informative SNPs between
the ancestral populations. Table 2 compares the allele fre-
quency distributions under each scenario of the different
databases and shows that there is a slight increase in the
proportion of rare variation in the Affymetrix and Illu-
mina groups. From the characterized HapMap, Affyme-
trix, and Illumina SNP databases, 17.3%, 2.6%, and 1.3%,
respectively, were 100% noninformative for ancestry.
A summary of the interpopulation differences using the
HapMap databases shows that a total of only 30 of the
interpopulation marker comparisons had very large fre-
quency differences or 100% informative for ancestry
(delta = 1) between the 2 ancestral groups (Table 2). The
few 100% informative SNPs for ancestry in these findings
are consistent with prior studies [33,34], showing that
most DNA variation is shared among human popula-
tions.BioData Mining 2009, 2:1 http://www.biodatamining.org/content/2/1/1
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Using a prespecified recommended allele frequency dif-
ference (delta) value of ≥ 0.3, on the average across the
databases and genome, 15% of HapMap, 19% of Affyme-
trix, and 15% of Illumina SNP sets were AIMs (Table 3).
However, only 15507 (0.42%) HapMap SNPs had an
allele frequency difference of 0.7 and above. Similar to the
case with CEU, there were large discrepancies in allele fre-
quencies between SNP data for Yoruban populations
from the different databases. For example, the reported
allele frequencies of the rs55543 SNP from the HapMap,
Affymetrix, and Illumina databases were 0.34, 0.31, and
0.42 generated from sample sizes of 120, 48, and 60 sam-
ples, respectively. We suspect that the differences in SNP
allele frequency data in the different databases were likely
due to small sample sizes and respective large sampling
errors of the estimates as suggested by Dvornyk et al. [23].
The SNP AIM characteristics with assigned rs numbers,
allele frequencies in each ethnic group, delta value, and
map positions are all posted on our website http://
www.ssg.uab.edu/downloads/admixture_mapping/
SNPAIMs.txt. All marker information in this data set is
freely and publicly available without restriction.
Table 2: Distribution of allele frequency differences (Yoruba vs. European) across SNP marker databases
Allele freq difference HapMap Affymetrix Illumina AIMs
SNPs % SNPs % SNPs % SNPs %
0 635890 17.26 12813 2.60 1392 1.27 - -
0.01–0.29 2477910 67.257 385585 78.28 91992 84.11 - -
0.3–0.50 440866 11.966 73066 14.83 15833 14.62 993 33.83
0.51–0.70 114055 3.096 18910 3.84 1515 51.63
0.71–0.90 14957 0.406 2138 0.44 - - 414 14.11
0.91–0.99 520 0.014 28 0.01 - - 12 0.40
1 3 0 0 . 0 0 1- - - ---
Chr = chromosome
Table 3: Number of AIMs and percentage with delta ≥ 0.3 (in parentheses) for HapMap, Affymetrix, Illumina and AIM databases.
HapMap SNPs Affymerix SNPs Illumina SNPs AIM SNPs
Chr Total delta (%) Total delta (%) Total delta (%) Total delta (%)
1 270009 36255 (13) 39418 4439 (11) 9820 1471 (15) 235 235 (100)
2 293090 46551 (16) 40633 4649 (11) 8702 1280(15) 217 217(100)
3 225937 35394 (16) 33120 3779 (11) 7207 1021(14) 178 178(100)
4 214465 33242 (16) 31339 3449 (11) 6000 929(15) 124 124(100)
5 221858 31821 (14) 31595 3245 (10) 6329 879(14) 129 129(100)
6 244251 32121 (13) 31130 3126 (10) 6579 894(14) 184 184(100)
7 182354 26745 (15) 25407 2785 (11) 5581 826(15) 121 121(100)
8 192846 32106 (17) 26948 3142 (12) 4891 751(15) 122 122(100)
9 162192 23800 (15) 22596 2447 (11) 4480 585(13) 108 108(100)
10 189583 26671 (14) 28217 3005 (11) 5240 784(15) 135 135(100)
11 180434 23850 (13) 28217 2767 (11) 5240 863(15) 154 154(100)
12 169898 23058 (14) 25998 2672 (11) 5928 768(14) 125 125(100)
13 142568 18327 (13) 24712 1909 (10) 5465 399(13) 71 71(100)
14 110229 16581 (15) 18910 1667 (11) 3093 499(15) 88 88(100)
15 95436 16511 (17) 15432 1778 (13) 3420 533(16) 83 83(100)
16 96742 14331 (15) 14190 1741(12) 3307 536(16) 95 95(100)
17 79038 12212 (16) 15069 1342(12) 3388 626(15) 115 115(100)
18 107243 15605 (15) 11127 1613(11) 4079 354(14) 79 79(100)
19 48447 6970 (14) 14631 620(10) 2570 439(12) 102 102(100)
20 108979 12941 (12) 6284 1357(11) 3520 431(14) 80 80(100)
21 43739 6775 (16) 12266 772(11) 3007 169(12) 54 54(100)
22 49009 6419 (13) 7014 620(10) 1381 304(16) 88 88(100)
X 102866 23368 (23) 6123 1867(18) 1886 640(18) 156 156(100)
Y 5 5 1 1  ( 2 0 ) - -----
Chr = chromosomeBioData Mining 2009, 2:1 http://www.biodatamining.org/content/2/1/1
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2. Number of overlapping AIMs selected from different 
platforms
We compared selected AIM lists from among the different
databases. Even though 57,000 Illumina 100 K SNPs are
in the HapMap dataset, there were no common SNPs
selected as AIMs when we used a 0.3 and above delta
threshold of informativeness. Interestingly, the recent
3011 AIM panel [19] developed from databases such as
Applied Biosystems, Applera, SeatleSNPs, and dbSNP is
well represented in HapMap (total of 1479 SNPs were
common with HapMap as AIMs). Affymetrix 500 K and
HapMap have about 365,000 common SNPs. However,
for AIMs with a delta value of ≥ 0.3, there were only
26,388 sets of SNPs overlapping between the 2 databases.
As AIMs, few SNPs appeared in both Affymetrix and the
recently developed AIM panel; the same was true for Hap-
Map, Affymetrix, and the recently developed AIM panel.
However, there was no overlap in the selected AIMs
among Affymetrix, Illumina, HapMap, and the recently
developed AIM panel (Table 4). This is not surprising
because the SNP selection criteria for each platform dif-
fered. For example, Affymetrix SNPs are based on proxim-
ity to a restriction site and even distribution across the
genome, whereas the Illumina platform SNPs are selected
in gene-rich regions and thus are not evenly distributed
across the genome [28]. Combining nonoverlapping
SNPs from different platforms seems a viable approach to
increase power and detect signals across the genome.
However, most SNPs are not fixed among ancestral popu-
lations and so we cannot rule out the chance that the delta
measures of informativeness pick different markers in the
different platforms. Moreover, the average sample size
(number of individuals) or DNA samples in each of the 2
populations used to estimate allele frequencies and the
laboratory procedures used vary between platforms. For
instance HapMap data were based on 120 samples,
Affymetrix was based on 48 samples, and Illumina used
60 samples. Hence, we believe that the selected SNPs that
are present in at least 2 platforms could be considered to
be the best candidates for admixture mapping.
3. Private SNP data set
We observed significant differences in allele frequencies of
few SNPs in the present study. These SNPs with significant
variation in allele frequencies in populations of different
ethnicity may be appropriate for studying the genetic basis
of between-ethnic differences in the rates of complex dis-
eases. Although the small sample sizes in this study pre-
clude any definite conclusion regarding the complete
absence of a particular allele in any given population, we
observed 30 HapMap SNPs (0.001%) that were segregat-
ing in only one population sample ("private SNPs"). Most
of these private SNPs (77%) were segregating in the Afri-
can sample, although private SNPs were also observed for
European populations. This may owe to the fact that Afri-
can populations harbor more unique polymorphic alleles
than non-African populations [35]. Follow-up studies of
Table 4: Number of overlapping SNP AIMs selected by different platforms (HapMap, Affymetrix, Illumina, and AIMs).
Chr H<->A H<->I H<->S A <->I A<->S I<->S H<->A<->I H<-> A<>S H<->I <->S A<->I <->S All
11 9 2 3 0 1 0 7 0 5 0 0 1 0 0 0
22 1 8 0 0 1 1 4 0 7 0 0 5 0 0 0
31 9 8 3 0 8 8 0 1 0 0 1 0 0 0
41 4 3 3 0 5 8 0 6 0 0 3 0 0 0
51 5 9 0 0 7 1 0 7 0 0 4 0 0 0
61 8 3 6 0 1 0 5 0 8 0 0 7 0 0 0
71 2 4 0 0 5 5 0 2 0 0 2 0 0 0
81 5 4 6 0 6 1 0 5 0 0 4 0 0 0
91 0 7 3 0 6 3 0 2 0 0 2 0 0 0
10 1275 0 69 0 5 0 0 2 0 0 0
11 1167 0 67 0 2 0 0 1 0 0 0
12 1071 0 67 0 6 0 0 5 0 0 0
13 1073 0 38 0 1 0 0 1 0 0 0
14 760 0 46 0 2 0 0 2 0 0 0
15 863 0 45 0 2 0 0 2 0 0 0
16 824 0 52 0 4 0 0 3 0 0 0
17 694 0 56 0 2 0 0 2 0 0 0
18 883 0 55 0 5 0 0 3 0 0 0
19 244 0 48 0 1 0 0 1 0 0 0
20 863 0 47 0 3 0 0 3 0 0 0
21 431 0 31 0 6 0 0 5 0 0 0
22 361 0 41 0 5 0 0 1 0 0 0
X1 0 7 5 0 9 5 0 7 0 0 5 0 0 0
Chr = chromosome, H = HapMap, A = Affymerix, I = Illumina, and S = AIMs identified by Smith et al. (2004)BioData Mining 2009, 2:1 http://www.biodatamining.org/content/2/1/1
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the highly differentiated regions might provide significant
insight into phenotypic diversity, selection and local
adaptation between populations. No private SNPs were
observed in the Affymetrix and Illumina data sets.
Discussion
The SNP databases are important resources for performing
genetic linkage, association, and admixture studies. Both
academic and commercial groups are developing large
numbers of genome-wide SNP datasets. These databases
now contain over 12.6 million SNPs. However, only a
small fraction of these SNPs are well characterized and
validated [21]. Users of these data sets have several com-
mon questions regarding the existing databases, including
the following: What is the frequency spectrum of the SNPs
in these databases? What is the distribution picture of
these SNPs across different ethnic and geographic popula-
tions? What fraction of the total number of SNPs is
already captured by these databases?
We mined and compared the HapMap SNP database
against Affymetrix 500 K and the gene centric Illumina
100 K SNP chips. This comparison suggests that a rela-
tively large fraction (> 80%) of SNPs in these databases do
not meet the cutoff for acceptable markers as AIMs [10],
which means that they are either of very low frequency or
not ancestry informative between the 2 ancestral popula-
tions. As a result, we developed and preset the AIM panels
for each database individually. Our analyses showed that
the SNP databases in their current status might have some
limitation for studies of complex disorders, especially in
different ethnic groups, as a result of incomplete or une-
ven representation of SNPs along the genome [23]. As
indicated above, the different databases have different sets
of SNPs. Because the SNP allele frequencies were deter-
mined by different genotyping labs that used different
sample sizes and genotyping methods (see Methods), it
would be difficult to perform several tests to assess data
quality and identify sources of experimental variation. In
critically evaluating our results, it is important to note that
our analyses, and hence interpretations, are subject to sev-
eral limitations. First, many of our analyses relied on data
derived from available databases with contents that are,
and will continue to be for some time, in a state of change.
Moreover, the allele frequencies across the platforms were
based on different sets of DNA samples. Therefore, our
results represent a snapshot based on currently available
data, and ultimately, when the human genome annota-
tion becomes more stable, it will be important to verify
these results. Second, the SNP allele frequencies were
determined by using relatively small sample sizes (see
Methods), and stochastic variation could affect the
robustness of our conclusions.
Several studies discussed the similarities between human
populations in terms of genetic constituents, and hence a
large sample size may enable the detection of small differ-
ences in rare outcomes. Although we observed a strong
correlation in allele frequencies between SNPs from dif-
ferent platforms (data not shown), confirming these allele
frequency estimates in a larger sample size will be impor-
tant. The analytical caveats associated with each database,
such as how surrogates are Yorubans or CEU to each
ancestral population and how much of the data (for
example, in HapMap) is transferable to the diverse popu-
lations in Africa where there is extreme adaptive variation
along the various countries is also debatable.
Most studies consider Europe as a relatively homogeneous
population. Consequently, it has been argued that Euro-
pean population stratification does not represent a sub-
stantial source of bias in epidemiologic studies [36].
However, recent autosomal SNP studies have highlighted
significant patterns of structure within Europe along a
north-south axis [37] and also the presence of several sig-
nificant axes of stratification within Europe, most promi-
nently in a northern-southeastern trend, but also along an
east-west axis. The study emphasized the importance of
considering population stratification in studies using
European and European-American individuals, and the
need to develop EuroAIMs (European ancestry informa-
tive markers) for ancestry estimation and correction [38].
Moreover, the fundamental theorem underpinning Hap-
Map is the common disease common variance (CD/CV)
hypothesis [39]. How much information we can capture
from rare variants is not clear [40].
Conclusion
We presented AIM databases for all SNPs that show prom-
ise in distinguishing ancestral populations and thus that
will be useful in admixture mapping for finding loci influ-
encing complex phenotypes. These databases will also be
useful for controlling stratification (or confounding fac-
tors) when the variation in admixture levels among indi-
viduals causes false-positive associations in genetic
association studies. This investment will result in a unique
genetic resource of high quality and global importance for
genetic studies in admixed populations. Its size and com-
plexity will allow systematic research into the genetics of
many complex disorders in admixed populations and
thus, by serving a wide variety of disciplines, will feed
research in this promising area for many years to come.
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